{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:19:35Z","timestamp":1790734775513,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s00228-026-04064-0","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T23:30:10Z","timestamp":1777505410000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Therapeutic impact of SGLT2 inhibitors following transcatheter aortic valve implantation: a grade-assessed systematic review and meta-analysis."],"prefix":"10.1007","volume":"82","author":[{"given":"Khadeeja Ali","family":"Hamzah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousif Hameed","family":"Kurmasha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Saad","family":"Al-Shammari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammedsadeq A.","family":"shweliya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Alsajad Hussein","family":"Al-Janabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Shahzaib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atef","family":"akoum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasar","family":"Sattar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"4064_CR1","unstructured":"Ancona\u2019 \u2019Roberta Pinto\u2019 \u2019Salvatore Comenale. Epidemiology of aortic valve stenosis (AS) and of aortic valve incompetence (AI): is the prevalence of AS\/AI similar in different parts of the world? [Internet]. Vol. 18. [cited 2022 Mar 30]. https:\/\/www.escardio.org\/Journals\/E-Journal-of-Cardiology-Practice\/Volume-18\/epidemiology-of-aortic-valve-stenosis-as-and-of-aortic-valve-incompetence-ai"},{"issue":"5","key":"4064_CR2","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1007\/s10741-023-10312-7","volume":"28","author":"M Avvedimento","year":"2023","unstructured":"Avvedimento M, Angellotti D, Ilardi F et al (2023) Acute advanced aortic stenosis. Heart Fail Rev 28(5):1101\u20131111. https:\/\/doi.org\/10.1007\/s10741-023-10312-7","journal-title":"Heart Fail Rev"},{"issue":"Suppl AB","key":"4064_CR3","doi-asserted-by":"publisher","first-page":"AB64","DOI":"10.4244\/EIJ-D-18-00653","volume":"14","author":"H Eltchaninoff","year":"2018","unstructured":"Eltchaninoff H, Durand E, Barbanti M, Abdel-Wahab M (2018) TAVI and valve performance: update on definitions, durability, transcatheter heart valve failure modes and management. EuroIntervention 14(Suppl AB):AB64\u201373","journal-title":"EuroIntervention"},{"key":"4064_CR4","doi-asserted-by":"crossref","unstructured":"Younes AM, Mahmoud AK, Kamel I, Albeyoumi H, Maraey A, Khalil M (2025) Outcomes of transcatheter aortic valve replacement in heart failure patients: Insights from the National Readmission Database. Cardiovasc Revascularization Med. Mar 5","DOI":"10.1016\/j.carrev.2025.03.002"},{"key":"4064_CR5","doi-asserted-by":"publisher","first-page":"1482918","DOI":"10.3389\/fcvm.2025.1482918","volume":"12","author":"Q Feng","year":"2025","unstructured":"Feng Q, Wu M, Mai Z (2025) Emerging horizons: clinical applications and multifaceted benefits of SGLT-2 inhibitors beyond diabetes. Front Cardiovasc Med 12:1482918","journal-title":"Front Cardiovasc Med"},{"issue":"5","key":"4064_CR6","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1093\/cvr\/cvae047","volume":"120","author":"A Preda","year":"2024","unstructured":"Preda A, Montecucco F, Carbone F et al (2024) SGLT2 inhibitors: from glucose-lowering to cardiovascular benefits. Cardiovasc Res 120(5):443\u2013460. https:\/\/doi.org\/10.1093\/cvr\/cvae047","journal-title":"Cardiovasc Res"},{"issue":"4","key":"4064_CR7","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3390\/kidneydial4040016","volume":"4","author":"A Cersosimo","year":"2024","unstructured":"Cersosimo A, Drera A, Adamo M, Metra M, Vizzardi E (2024) Exploring the cardiorenal benefits of SGLT2i: a comprehensive review. Kidney Dialysis 4(4):184\u2013202","journal-title":"Kidney Dialysis"},{"issue":"1","key":"4064_CR8","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1186\/s12933-024-02504-8","volume":"23","author":"P Paolisso","year":"2024","unstructured":"Paolisso P, Belmonte M, Gallinoro E et al (2024) SGLT2-inhibitors in diabetic patients with severe aortic stenosis and cardiac damage undergoing transcatheter aortic valve implantation (TAVI). Cardiovasc Diabetol 23(1):420 Published 2024 Nov 21. https:\/\/doi.org\/10.1186\/s12933-024-02504-8","journal-title":"Cardiovasc Diabetol"},{"issue":"15","key":"4064_CR9","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","volume":"383","author":"M Packer","year":"2020","unstructured":"Packer M, Anker SD, Butler J, Filippatos G, Pocock SJ, Carson P, Januzzi J, Verma S, Tsutsui H, Brueckmann M, Jamal W (2020) Cardiovascular and renal outcomes with empagliflozin in heart failure. N Engl J Med 383(15):1413\u20131424","journal-title":"N Engl J Med"},{"issue":"21","key":"4064_CR10","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","volume":"381","author":"JJ McMurray","year":"2019","unstructured":"McMurray JJ, Solomon SD, Inzucchi SE, K\u00f8ber L, Kosiborod MN, Martinez FA, Ponikowski P, Sabatine MS, Anand IS, B\u011blohl\u00e1vek J, B\u00f6hm M (2019) Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med 381(21):1995\u20132008","journal-title":"N Engl J Med"},{"issue":"14","key":"4064_CR11","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1056\/NEJMoa2500366","volume":"392","author":"S Raposeiras-Roubin","year":"2025","unstructured":"Raposeiras-Roubin S, Amat-Santos IJ, Rossello X, Gonz\u00e1lez Ferreiro R, Gonz\u00e1lez Berm\u00fadez I, Lopez Otero D, Nombela-Franco L, Gheorghe L, Diez JL, Baladr\u00f3n Zorita C, Baz JA (2025) Dapagliflozin in patients undergoing transcatheter aortic-valve implantation. N Engl J Med 392(14):1396\u20131405","journal-title":"N Engl J Med"},{"key":"4064_CR12","first-page":"n71","volume":"29","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ Published online March 29:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ Published online March"},{"key":"4064_CR13","unstructured":"Rohatgi A, Webplotdigitizer (2020) Version 4.5. URL https:\/\/automerisio\/WebPlotDigitizer 411:860"},{"issue":"1","key":"4064_CR14","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12874-021-01308-8","volume":"21","author":"N Liu","year":"2021","unstructured":"Liu N, Zhou Y, Lee JJ (2021) IPDfromKM: reconstruct individual patient data from published Kaplan-Meier survival curves. BMC Med Res Methodol 21(1):111","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"4064_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-2288-12-9","volume":"12","author":"P Guyot","year":"2012","unstructured":"Guyot P, Ades AE, Ouwens MJ, Welton NJ (2012) Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves. BMC Med Res Methodol 12(1):9","journal-title":"BMC Med Res Methodol"},{"key":"4064_CR16","doi-asserted-by":"crossref","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366 l4898. Published 2019 Aug 28. https:\/\/doi.org\/10.1136\/bmj.l4898","DOI":"10.1136\/bmj.l4898"},{"key":"4064_CR17","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JAC Sterne","year":"2016","unstructured":"Sterne JAC, Hern\u00e1n MA, Reeves BC, Savovi\u0107 J, Berkman ND, Viswanathan M, Henry D, Altman DG, Ansari MT, Boutron I (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355:i4919","journal-title":"BMJ"},{"issue":"5","key":"4064_CR18","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/j.1398-9995.2009.01973.x","volume":"64","author":"JL Bro\u017cek","year":"2009","unstructured":"Bro\u017cek JL, Akl EA, Alonso-Coello P, Lang D, Jaeschke R, Williams JW, Phillips B, Lelgemann M, Lethaby A, Bousquet J, Guyatt GH (2009) Grading quality of evidence and strength of recommendations in clinical practice guidelines: part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions. Allergy 64(5):669\u2013677","journal-title":"Allergy"},{"key":"4064_CR19","doi-asserted-by":"publisher","unstructured":"Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, Carpenter J, R\u00fccker G, Harbord RM, Schmid CH, Tetzlaff J, Deeks JJ, Peters J, Macaskill P, Schwarzer G, Duval S, Altman DG, Moher D, Higgins JP (2011) Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 343:d4002. https:\/\/doi.org\/10.1136\/bmj.d4002. PMID: 21784880","DOI":"10.1136\/bmj.d4002"},{"issue":"19","key":"4064_CR20","doi-asserted-by":"publisher","first-page":"7001","DOI":"10.3390\/jcm14197001","volume":"14","author":"O Morel","year":"2025","unstructured":"Morel O, Granier A, Lochon L, Trimaille A, Bisson A, Marchandot B, Bernard A, Fauchier L (2025) Association of SGLT2 Inhibitors with Mortality and Bioprosthesis Valve Failure After TAVR: A Propensity-Matched Cohort Study. J Clin Med 14(19):7001","journal-title":"J Clin Med"},{"issue":"1","key":"4064_CR21","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12933-025-02773-x","volume":"24","author":"P Paolisso","year":"2025","unstructured":"Paolisso P, Belmonte M, Gallinoro E, Scarsini R, Bergamaschi L, Portolan L, Armillotta M, Esposito G, Moscarella E, Montalto C, De Oliveira EK (2025) Impact of SGLT2-inhibitors on acute kidney injury in diabetic patients with severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI). Cardiovasc Diabetol 24(1):221","journal-title":"Cardiovasc Diabetol"},{"key":"4064_CR22","doi-asserted-by":"crossref","unstructured":"Obeidat O, Alayyat A, Naser A, Ghanem F, Jabri A, Brankovic M, Jiao T, Ruzieh M, Haddad A, Alexy T, Villablanca P (2025) Impact of SGLT2 inhibitors on long-term outcomes in TAVI patients with heart failure: a propensity-matched analysis. Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition). Nov 11","DOI":"10.1016\/j.rec.2025.10.016"},{"key":"4064_CR23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(18)32590-X","volume":"393","author":"TA Zelniker","year":"2019","unstructured":"Zelniker TA, Wiviott SD, Raz I et al (2019) SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. Lancet 393:31\u201339. https:\/\/doi.org\/10.1016\/S0140-6736(18)32590-X","journal-title":"Lancet"},{"issue":"3","key":"4064_CR24","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s10741-021-10079-9","volume":"27","author":"M Nikolic","year":"2022","unstructured":"Nikolic M, Zivkovic V, Jovic JJ, Sretenovic J, Davidovic G, Simovic S, Djokovic D, Muric N, Bolevich S, Jakovljevic V (2022) SGLT2 inhibitors: a focus on cardiac benefits and potential mechanisms. Heart Fail Rev 27(3):935\u2013949. https:\/\/doi.org\/10.1007\/s10741-021-10079-9. Epub 2021 Feb 3. PMID: 33534040","journal-title":"Heart Fail Rev"},{"issue":"2","key":"4064_CR25","first-page":"150","volume":"8","author":"K Nilsson","year":"2022","unstructured":"Nilsson K, Buccheri S, Christersson C, Koul S, Nilsson J, Petursson P, Renlund H, R\u00fcck A, James S (2022) Causes, pattern, predictors, and prognostic implications of new hospitalizations after transcatheter aortic valve implantation: a long-term nationwide observational study. Eur Heart Journal-Quality Care Clin Outcomes 8(2):150\u2013160","journal-title":"Eur Heart Journal-Quality Care Clin Outcomes"},{"issue":"4","key":"4064_CR26","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2459\/JCM.0000000000001591","volume":"25","author":"M Metra","year":"2024","unstructured":"Metra M, Radulescu CI, Cersosimo A et al (2024) Quality of life in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation: tools and evidence. J Cardiovasc Med (Hagerstown) 25(4):259\u2013270. https:\/\/doi.org\/10.2459\/JCM.0000000000001591","journal-title":"J Cardiovasc Med (Hagerstown)"},{"issue":"2","key":"4064_CR27","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/ejhf.3145","volume":"26","author":"L Scisciola","year":"2024","unstructured":"Scisciola L, Paolisso P, Belmonte M, Gallinoro E, Delrue L, Taktaz F, Fontanella RA, Degrieck I, Pesapane A, Casselman F, Puocci A (2024) Myocardial sodium\u2013glucose cotransporter 2 expression and cardiac remodelling in patients with severe aortic stenosis: The BIO-AS study. Eur J Heart Fail 26(2):471\u2013482","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"4064_CR28","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.jacbts.2020.02.004","volume":"5","author":"GD Lopaschuk","year":"2020","unstructured":"Lopaschuk GD, Verma S (2020) Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: A State-of-the-Art Review. JACC Basic Transl Sci 5(6):632\u2013644 PMID: 32613148; PMCID: PMC7315190","journal-title":"JACC Basic Transl Sci"},{"issue":"4","key":"4064_CR29","first-page":"e20240060","volume":"4","author":"FP Peres-Filho","year":"2024","unstructured":"Peres-Filho FP, Silva SU, Peres FP, Kerche LE (2024) Heart Failure Treatment with SGLT2 Inhibitors: A Systematic Review with Meta-Analysis. ABC Heart Fail Cardiomyop 4(4):e20240060","journal-title":"ABC Heart Fail Cardiomyop"},{"key":"4064_CR30","unstructured":"Jain H, Soni K, Jain J, Goyal A, Passey S, Goldsweig AM Sodium-Glucose Cotransporter-2 Inhibitors Following Transcatheter Aortic Valve Replacement: A Meta-Analysis. Cardiol Rev 10\u201397"},{"issue":"1","key":"4064_CR31","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12933-023-01814-7","volume":"22","author":"C Sardu","year":"2023","unstructured":"Sardu C, Trotta MC, Sasso FC, Sacra C, Carpinella G, Mauro C, Minicucci F, Calabr\u00f2 P, D\u2019Amico M, D\u2019Ascenzo F, De Filippo O (2023) SGLT2-inhibitors effects on the coronary fibrous cap thickness and MACEs in diabetic patients with inducible myocardial ischemia and multi vessels non-obstructive coronary artery stenosis. Cardiovasc Diabetol 22(1):80","journal-title":"Cardiovasc Diabetol"},{"key":"4064_CR32","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.amjcard.2023.12.056","volume":"214","author":"A Kurozumi","year":"2024","unstructured":"Kurozumi A, Shishido K, Yamashita T, Sato D, Uchida S, Koyama E, Tamaki Y, Hayashi T, Miyashita H, Yokoyama H, Ochiai T (2024) Sodium-glucose cotransporter-2 inhibitors stabilize coronary plaques in acute coronary syndrome with diabetes mellitus. Am J Cardiol 214:47\u201354","journal-title":"Am J Cardiol"},{"issue":"1","key":"4064_CR33","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s12933-024-02368-y","volume":"23","author":"T Zhang","year":"2024","unstructured":"Zhang T, Gao X, Chen T, Zhang H, Zhang X, Xin Y, Shi D, Du Y, Xu L, Zhou Y (2024) Longitudinal assessment of coronary plaque regression related to sodium\u2013glucose cotransporter-2 inhibitor using coronary computed tomography angiography. Cardiovasc Diabetol 23(1):267","journal-title":"Cardiovasc Diabetol"},{"key":"4064_CR34","doi-asserted-by":"publisher","first-page":"100933","DOI":"10.1016\/j.eclinm.2021.100933","volume":"36","author":"R Cardoso","year":"2021","unstructured":"Cardoso R, Graffunder FP, Ternes CMP, Fernandes A, Rocha AV, Fernandes G, Bhatt DL (2021) SGLT2 inhibitors decrease cardiovascular death and heart failure hospitalizations in patients with heart failure: A systematic review and meta-analysis. EClinicalMedicine 36:100933 PMID: 34308311; PMCID: PMC8257984","journal-title":"EClinicalMedicine"},{"issue":"1","key":"4064_CR35","doi-asserted-by":"publisher","first-page":"15364","DOI":"10.1038\/s41598-021-94945-4","volume":"11","author":"WH Tsai","year":"2021","unstructured":"Tsai WH, Chuang SM, Liu SC, Lee CC, Chien MN, Leung CH, Liu SJ, Shih HM (2021) Effects of SGLT2 inhibitors on stroke and its subtypes in patients with type 2 diabetes: a systematic review and meta-analysis. Sci Rep 11(1):15364. https:\/\/doi.org\/10.1038\/s41598-021-94945-4PMID: 34321571; PMCID: PMC8319393","journal-title":"Sci Rep"},{"issue":"15","key":"4064_CR36","doi-asserted-by":"publisher","first-page":"5306","DOI":"10.3390\/jcm14155306","volume":"14","author":"SB Suresh","year":"2025","unstructured":"Suresh SB, Prasad A, Ubaid MF, Farooq S, Hajra A, Jaiswal V, Malik A, Fonarow GC, Bandyopadhyay D (2025) SGLT2 Inhibitors and the Risk of Arrhythmias in Heart Failure: A Network Meta-Analysis. J Clin Med 14(15):5306. https:\/\/doi.org\/10.3390\/jcm14155306PMID: 40806928; PMCID: PMC12347573","journal-title":"J Clin Med"},{"key":"4064_CR37","doi-asserted-by":"publisher","first-page":"111811","DOI":"10.1016\/j.jclinane.2025.111811","volume":"103","author":"LIP Snel","year":"2025","unstructured":"Snel LIP, Oosterom-Eijmael MJP, Rampanelli E, Lankadeva YR, Plummer MP, Preckel B, Hermanides J, van Raalte DH, Hulst AH (2025) The effects of sodium-glucose transporter 2 inhibition on cardiac surgery-associated acute kidney injury: An open-label randomized pilot study. J Clin Anesth 103:111811 Epub 2025 Mar 27. PMID: 40153894","journal-title":"J Clin Anesth"},{"key":"4064_CR38","doi-asserted-by":"crossref","unstructured":"Zhang C, Liu J, Liu W, Liu H, Sun P, Fang Y, Yang J, Sun H, Li Y, Foo RS, Sia CH (2025 Jun) Relative Hyperglycemia and In-Hospital Bleeding Across Glycemic Status in Patients on High-Intensity Antithrombotic Therapy. Circ J 6:CJ\u201325","DOI":"10.1253\/circj.CJ-25-0017"},{"issue":"4","key":"4064_CR39","doi-asserted-by":"publisher","first-page":"R113","DOI":"10.1530\/EJE-17-0832","volume":"178","author":"RL Esterline","year":"2018","unstructured":"Esterline RL, Vaag A, Oscarsson J, Vora J (2018) MECHANISMS IN ENDOCRINOLOGY: SGLT2 inhibitors: clinical benefits by restoration of normal diurnal metabolism? Eur J Endocrinol 178(4):R113\u2013R125","journal-title":"Eur J Endocrinol"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-04064-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-026-04064-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-04064-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T02:53:27Z","timestamp":1783652007000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-026-04064-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["4064"],"URL":"https:\/\/doi.org\/10.1007\/s00228-026-04064-0","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"assertion":[{"value":"4 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable; no identifiable individual patient data are presented.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"137"}}